Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report

BACKGROUND: The oral multi-kinase inhibitor sunitinib malate improves the survival of patients with gastrointestinal stromal tumors (GIST) after the disease progresses or intolerance to imatinib mesylate develops. Urinary fistulae arising during treatment with sunitinib for GIST have not been descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Koichiro, Otsu, Satoshi, Morinaga, Ryotaro, Kawano, Sakura, Hirashima, Yoshinori, Sakashita, Hiroyuki, Shirao, Kuniaki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988710/
https://www.ncbi.nlm.nih.gov/pubmed/21040530
http://dx.doi.org/10.1186/1471-230X-10-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988710/
https://www.ncbi.nlm.nih.gov/pubmed/21040530
http://dx.doi.org/10.1186/1471-230X-10-128

Ejemplares similares